Morgan Stanley, on Monday, forecast UK's economic growth would be less than 1% this year, echoing the estimate of its Wall ...
Morgan Stanley (NYSE:MS) adjusted its stance on Intellia Therapeutics shares, downgrading the biotechnology company from Overweight to Equalweight. Accompanying this change, the firm also ...